Clinical Trial Update: Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease [Phase 4]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 4 study evaluating adventitial dexamethasone for peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Dexamethasone (adventitial delivery) (dexamethasone)

Snippet

Sponsor: Mercator MedSystems, Inc. | Conditions: Peripheral Arterial Diseases | Phase 4 | Status: COMPLETED